{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:36:17Z","timestamp":1762508177831},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Ethiopia has shown significant efforts to address the burden of TB\/HIV comorbidity through the TB\/HIV collaborative program. However, these diseases are still the highest cause of death in the country. Therefore, this systematic review and meta-analysis evaluated this program by investigating the overall proportion of unknown HIV status among TB patients using published studies in Ethiopia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a systematic review and meta-analysis of published studies in Ethiopia. We identified the original studies using the databases MEDLINE\/PubMed, and Google Scholar. The heterogeneity across studies was assessed using Cochran\u2019s Q test and I <jats:sup>2<\/jats:sup> statistics. The Begg\u2019s rank correlation and the Egger weighted regression tests were assessed for the publication bias. We estimated the pooled proportion of unknown HIV status among TB patients using the random-effects model.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Overall, we included 47 studies with 347,896\u2009TB patients eligible for HIV test. The pooled proportion of unknown HIV status among TB patients was 27%(95% CI; 21\u201334%) and with a substantial heterogeneity (I<jats:sup>2<\/jats:sup>\u00a0=\u200999.9%). In the subgroup analysis, the pooled proportion of unknown HIV status was 39% (95% CI; 25\u201354%) among children and 20% (95% CI; 11\u201330%) among adults. In the region based analysis, the highest pooled proportion of unknown HIV status was in Gambella, 38% (95% CI; 16\u201360%) followed by Addis Ababa, 34%(95% CI; 12\u201355%), Amhara,30%(95% CI; 21\u201340%),and Oromia, 23%(95% CI; 9\u201338%). Regarding the study facilities, the pooled proportion of unknown HIV status was 33% (95% CI; 23\u201343%) in the health centers and 26%(95% CI; 17\u201335%) in the hospitals. We could not identify the high heterogeneity observed in this review and readers should interpret the results of the pooled proportion analysis with caution.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In Ethiopia, about one-third of tuberculosis patients had unknown HIV status. This showed a gap to achieve the currently implemented 90\u201390-90 HIV\/AIDS strategic plan in Ethiopia, by 2020. Therefore, Ethiopia should strengthen TB\/HIV collaborative activities to mitigate the double burden of diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12889-020-09117-2","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T12:04:05Z","timestamp":1593432245000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unknown HIV status and the TB\/HIV collaborative control program in Ethiopia: systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Balew","family":"Arega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Minda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getachew","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulugeta","family":"Endale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asnake","family":"Agunie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"9117_CR1","volume-title":"Guidelines for HIV surveillance among tuberculosis patients","author":"WHO","year":"2004","unstructured":"WHO. Guidelines for HIV surveillance among tuberculosis patients. 2nd ed. Geneva: World Health Organization; 2004.","edition":"2"},{"key":"9117_CR2","unstructured":"WHO. Global tuberculosis report. Geneva; 2017. p. 2017."},{"key":"9117_CR3","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1086\/651475","volume":"50","author":"KH Mayer","year":"2010","unstructured":"Mayer KH, Hamilton CD. Synergistic pandemics: confronting the global HIV and Tuberculosis epidemics. Clin Infect Dis. 2010;50:S67\u201370.","journal-title":"Clin Infect Dis"},{"key":"9117_CR4","volume-title":"A strategic framework to decrease the burden of TB\/HIV","author":"WHO","year":"2002","unstructured":"WHO. A strategic framework to decrease the burden of TB\/HIV. Geneva: World Health Organization; 2002."},{"issue":"1","key":"9117_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2458-10-177","volume":"10","author":"I Sendagire","year":"2010","unstructured":"Sendagire I, Schreuder I, Mubiru M, et al. Low HIV testing rates among tuberculosis patients in Kampala, Uganda. BMC Public Health. 2010;10(1):177.","journal-title":"BMC Public Health"},{"key":"9117_CR6","volume-title":"WHO policy on collaborative TB\/ HIV activities: guidelines for national programs and other stakeholders. WHO\/HTM\/TB\/2004.330","author":"WHO","year":"2012","unstructured":"WHO. WHO policy on collaborative TB\/ HIV activities: guidelines for national programs and other stakeholders. WHO\/HTM\/TB\/2004.330. Geneva: WHO; 2012."},{"key":"9117_CR7","volume-title":"Global Tuberculosis Control: WHO report 2016 (WHO\/HTM\/TB\/2016.13)","author":"WHO","year":"2016","unstructured":"WHO. Global Tuberculosis Control: WHO report 2016 (WHO\/HTM\/TB\/2016.13). Geneva: WHO; 2016."},{"key":"9117_CR8","volume-title":"Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia","author":"The Federal Ministry of Health of Ethiopia","year":"2007","unstructured":"The Federal Ministry of Health of Ethiopia. Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia. 2007."},{"key":"9117_CR9","volume-title":"TB\/HIV implementation guideline 2008","author":"The Federal Ministry of Health of Ethiopia","year":"2008","unstructured":"The Federal Ministry of Health of Ethiopia. TB\/HIV implementation guideline 2008. Addis Ababa: Ministry of Health; 2008."},{"key":"9117_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2018.10.022","volume":"78","author":"Y Assefa","year":"2019","unstructured":"Assefa Y, Gilksa FC, Judith Deana J. Towards achieving the fast-track targets and ending the epidemic of HIV\/AIDS in Ethiopia: Successes and challenges. Int J Infect Dis. 2019;78:57\u201364.","journal-title":"Int J Infect Dis"},{"key":"9117_CR11","volume-title":"UNAIDS Data","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2017","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS Data 2017."},{"key":"9117_CR12","volume-title":"Report on National TB\/HIV Sentinel Surveillance (April 2010\u2013June 2015)","author":"Ethiopian Public Health Institute (EPHI)","year":"2015","unstructured":"Ethiopian Public Health Institute (EPHI). Report on National TB\/HIV Sentinel Surveillance (April 2010\u2013June 2015). 2015."},{"key":"9117_CR13","volume-title":"90\u201390-90: an ambitious treatment target to help end the AIDS epidemic","author":"Joint United Nations programme on HIV\/AIDS (UNAIDS)","year":"2014","unstructured":"Joint United Nations programme on HIV\/AIDS (UNAIDS). 90\u201390-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: Joint United Nations Programme on HIV\/ AIDS (UNAIDS); 2014."},{"key":"9117_CR14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12879-018-3214-6","volume":"18","author":"T Girum","year":"2018","unstructured":"Girum T, Wasie A, Worku A. Trend of HIV\/AIDS for the last 26 years and predicting achievement of the 90-90-90 HIV prevention targets by 2020 in Ethiopia: a time series analysis. BMC Infect Dis. 2018;18:320.","journal-title":"BMC Infect Dis"},{"key":"9117_CR15","doi-asserted-by":"crossref","unstructured":"Jamieson D and Kellerman S. The 90 90 90 strategies to end the HIV Pandemic by 2030: Can the supply chain handle it Journal of the International AIDS Society 2016; 19:20917.","DOI":"10.7448\/IAS.19.1.20917"},{"issue":"6","key":"9117_CR16","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analysis: the Prisma statement. PLoS Med. 2009;6(6):e1000097.","journal-title":"PLoS Med"},{"key":"9117_CR17","unstructured":"The Joanna Briggs Institute Critical Appraisal tools for JBI Systematic Reviews. Checklist for Prevalence Studies: Joanna Briggs Institute; 2017."},{"key":"9117_CR18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"MF Freeman","year":"1950","unstructured":"Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607\u201311.","journal-title":"Ann Math Stat"},{"key":"9117_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ. 2003;327:557.","journal-title":"BMJ"},{"key":"9117_CR20","doi-asserted-by":"crossref","unstructured":"Viechtbauer W, Cheung MWL. Outlier and influence diagnostics for Meta-analysis. Res Synth Methods. 2010:112\u201325.","DOI":"10.1002\/jrsm.11"},{"key":"9117_CR21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s13104-017-3020-z","volume":"10","author":"B Mondale","year":"2017","unstructured":"Mondale B, Medihn G, Teklu T, et al. A retrospective study on tuberculosis treatment outcomes at Jinka general hospital, southern Ethiopia. BMC Res Notes. 2017;10:680.","journal-title":"BMC Res Notes"},{"key":"9117_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12890-018-0600-1","volume":"18","author":"K Adane","year":"2018","unstructured":"Adane K, Spigt M, Dinant GJ. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis. BMC Pulm Med. 2018;18:37.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"9117_CR23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3855\/jidc.5963","volume":"9","author":"E Ejeta","year":"2015","unstructured":"Ejeta E, Chala M, Gebeyaw AG, et al. Outcome of Tuberculosis patients under observed short-course treatment in western Ethiopia. J Infect Dev Ctries. 2015;9(7):752\u20139.","journal-title":"J Infect Dev Ctries"},{"key":"9117_CR24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1186\/s12879-017-2882-y","volume":"17","author":"F Getnet","year":"2017","unstructured":"Getnet F, Sileshi H, Seifu W, et al. Do retreatment tuberculosis patients need special treatment response follow-up beyond the standard regimen? Finding of a five-year retrospective study in pastoralist setting. BMC Infect Dis. 2017;17:762.","journal-title":"BMC Infect Dis"},{"key":"9117_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2458-10-215","volume":"10","author":"JM Ramos","year":"2010","unstructured":"Ramos JM, Reyes F. Tesfamariam A children and adult tuberculosis in a rural hospital in Southeast Ethiopia: a ten-year retrospective study. BMC Public Health. 2010;10:215.","journal-title":"BMC Public Health"},{"key":"9117_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2431-14-61","volume":"14","author":"AW HailuD","year":"2014","unstructured":"HailuD AW, Belay M. Childhood tuberculosis and its treatment outcomes in Addis Ababa: a 5-years retrospective study. BMC Pediatr. 2014;14:61.","journal-title":"BMC Pediatr"},{"key":"9117_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12879-019-3943-1","volume":"19","author":"B Arega","year":"2019","unstructured":"Arega B, Menbere F, Getachew Y. Prevalence of rifampicin-resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis. 2019;19:307.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"9117_CR28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1371\/journal.pone.0153239","volume":"11","author":"G Gebremariam","year":"2016","unstructured":"Gebremariam G, Asmamaw G, Hussen M, et al. Impact of HIV status on treatment outcome of Tuberculosis patients registered at ArsiNegele health center, southern Ethiopia: a six-year retrospective study. PLoS One. 2016;11(4):144\u20136.","journal-title":"PLoS One"},{"key":"9117_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fmed.2018.00038","volume":"5","author":"K Tafess","year":"2018","unstructured":"Tafess K, Beyen TK, Abera A, et al. Treatment outcomes of Tuberculosis at Asella teaching hospital, Ethiopia: Ten Years\u2019 Retrospective Aggregated Data. Front Med. 2018;5:38.","journal-title":"Front Med"},{"issue":"12","key":"9117_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144244","volume":"10","author":"A Birlie","year":"2015","unstructured":"Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to death and associated factors among Tuberculosis patients in DangilaWoreda, Northwest Ethiopia. PLoS One. 2015;10(12):1\u201310.","journal-title":"PLoS One"},{"issue":"1","key":"9117_CR31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13104-018-3129-8","volume":"11","author":"A Melese","year":"2018","unstructured":"Melese A, Zeleke B. Factors associated with poor treatment outcome of tuberculosis in Debre Tabor, Northwest Ethiopia. BMC Res Notes. 2018;11(1):451\u20133.","journal-title":"BMC Res Notes"},{"issue":"3","key":"9117_CR32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4314\/ejhs.v28i3.13","volume":"28","author":"Y Berihun","year":"2017","unstructured":"Berihun Y, Nguse T, Gebretekle G. Prevalence of Tuberculosis and treatment outcomes of patients with Tuberculosis among inmates in Debrebirhan prison, north Shoa Ethiopia. Ethiop J Health Sci. 2017;28(3):347.","journal-title":"Ethiop J Health Sci"},{"key":"9117_CR33","doi-asserted-by":"crossref","unstructured":"Endris M, Moge F, Belyhun Y. Treatment Outcome of Tuberculosis Patients at Enfraz Health Center, Northwest Ethiopia: A Five-Year Retrospective Study. Hindawi; 2014. ID 726193.","DOI":"10.1155\/2014\/726193"},{"key":"9117_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/IDR.S135935","volume":"10","author":"KJ Jaleta","year":"2017","unstructured":"Jaleta KJ, Baye MG, Gelaw GB. Rifampicin-resistant mycobacterium tuberculosis among tuberculosis-presumptive cases at the University of Gondar Hospital, Northwest Ethiopia. Infect Drug Resist. 2017;10:185\u201392.","journal-title":"Infect Drug Resist"},{"key":"9117_CR35","first-page":"75","volume":"28","author":"A Simieneh","year":"2017","unstructured":"Simieneh A, Hailemariam M, Amsalu A. HIV screening among TB patients and level of antiretroviral therapy and co-trimoxazole preventive therapy for TB\/HIV patients in Hawassa University Referral Hospital: a five-year retrospective study. Pan Afri Med J. 2017;28:75.","journal-title":"Pan Afri Med J"},{"issue":"3","key":"9117_CR36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4314\/ahs.v16i3.4","volume":"16","author":"D Mekonnen","year":"2016","unstructured":"Mekonnen D, Derbie A, Mekonnen H, et al. Profile and treatment outcomes of patients with tuberculosis in northeastern Ethiopia: a cross-sectional study. Afr Health Sci. 2016;16(3):663\u201370.","journal-title":"Afr Health Sci"},{"key":"9117_CR37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/1471-2458-12-537","volume":"12","author":"G Berhe","year":"2012","unstructured":"Berhe G, Enquselassie F. AseffaA. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray region, northern Ethiopia. BMC Public Health. 2012;12:537.","journal-title":"BMC Public Health"},{"key":"9117_CR38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12889-016-3193-8","volume":"16","author":"G Tilahun","year":"2016","unstructured":"Tilahun G, GebreSelassie S. Treatment outcomes of childhood tuberculosis in Addis Ababa: a five-year retrospective analysis. BMC Public Health. 2016;16:612.","journal-title":"BMC Public Health"},{"key":"9117_CR39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12889-016-3362-9","volume":"16","author":"Y Zenebe","year":"2016","unstructured":"Zenebe Y, AdemY MD. Profile of tuberculosis, and its response to anti-TB drugs among tuberculosis patients treated under the TB control program at FelegeHiwot Referral Hospital, Ethiopia. BMC Public Health. 2016;16:688.","journal-title":"BMC Public Health"},{"key":"9117_CR40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/IDR.S134369","volume":"10","author":"D Assefa","year":"2017","unstructured":"Assefa D, Seyoum B, Oljira L. Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2017;10:209\u201321.","journal-title":"Infect Drug Resist"},{"key":"9117_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.11648\/j.iji.20140202.11","volume":"2","author":"W Sintayehu","year":"2014","unstructured":"Sintayehu W, Abera A, Gebru T, et al. Trends of Tuberculosis treatment outcomes at Mizan-Aman general hospital, Southwest Ethiopia: a retrospective study. Int J Immunol. 2014;2:11\u20135.","journal-title":"Int J Immunol"},{"issue":"1","key":"9117_CR42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4314\/ejhs.v26i1.11","volume":"26","author":"F Tefera","year":"2016","unstructured":"Tefera F, Dejene T, Tewelde T. Treatment outcomes of Tuberculosis patients at DebreBerhan hospital, Amhara region, northern Ethiopia. Ethiop J Health Sci. 2016;26(1):125\u20137.","journal-title":"Ethiop J Health Sci"},{"key":"9117_CR43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4172\/2332-0877.1000211","volume":"3","author":"G Asebe","year":"2015","unstructured":"Asebe G, Dissasa H, Teklu T, et al. Treatment outcome of Tuberculosis patients at Gambella hospital, Southwest Ethiopia: Three-year Retrospective Study. J Infect Dis Ther. 2015;3:211.","journal-title":"J Infect Dis Ther"},{"key":"9117_CR44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.11604\/pamj.2017.27.25.10120","volume":"27","author":"ZT Kebede","year":"2017","unstructured":"Kebede ZT, Taye BW, Matebe YH. Childhood tuberculosis: management and treatment outcomes among children in Northwest Ethiopia: a cross-sectional study. Pan African Medical Journal. 2017;27:25.","journal-title":"Pan African Medical Journal"},{"key":"9117_CR45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijid.2018.10.001","volume":"77","author":"S Sisaya","year":"2018","unstructured":"Sisaya S, Mekonen A, Abera A. An evaluation of collaboration in the TB and HIV control program in Oromia region, Ethiopia: seven years of retrospective data. Int J Infect Dis. 2018;77:74\u201381.","journal-title":"Int J Infect Dis"},{"key":"9117_CR46","doi-asserted-by":"crossref","unstructured":"Biruk M, Yimam B, Abrha H. Treatment Outcomes of Tuberculosis and Associated Factors in an Ethiopian University Hospital: Hindawi; 2016. ID 8504629.","DOI":"10.1155\/2016\/8504629"},{"issue":"5","key":"9117_CR47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21767\/1791-809X.1000598","volume":"12","author":"B Yakob","year":"2018","unstructured":"Yakob B, Alemseged F, Paulos W, Badacho AS. Trends in treatment success rate and associated factors among Tuberculosis patients in Ethiopia: a retrospective cohort study. Health Sci J. 2018;12(5):598.","journal-title":"Health Sci J"},{"issue":"03","key":"9117_CR48","first-page":"121","volume":"04","author":"Z Addis","year":"2013","unstructured":"Addis Z, Birhan W, Alemu A. Treatment outcome of Tuberculosis patients in Azezo health center, North West Ethiopia. IJBAR. 2013;04(03):121\u20134.","journal-title":"IJBAR"},{"key":"9117_CR49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jiph.2013.01.002","volume":"6","author":"D Yadetaa","year":"2013","unstructured":"Yadetaa D, Alemsegedb F, Biadgilign S. Provider-starting HIV testing and counseling among tuberculosis patients in a hospital in the Oromia region of Ethiopia. J Infect Public Health. 2013;6:222\u20139.","journal-title":"J Infect Public Health"},{"key":"9117_CR50","doi-asserted-by":"crossref","unstructured":"Akessa GM,Tadesse M,Abebe G. Survival Analysis of Loss to Follow-Up Treatment among Tuberculosis Patients at Jimma University Specialized Hospital, Jimma, Southwest Ethiopia. Hindawi 2015; ID 923025.","DOI":"10.1155\/2015\/923025"},{"issue":"1","key":"9117_CR51","first-page":"141","volume":"57","author":"M Yilma","year":"2019","unstructured":"Yilma M. The effect of Hiv co-infection on Tuberculosis treatment in a zonal referral hospital in Ethiopia: a retrospective cohort study. Ethiop Med J. 2019;57(1):141\u20133.","journal-title":"Ethiop Med J"},{"key":"9117_CR52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4172\/2161-1068.1000194","volume":"5","author":"B Ayele","year":"2015","unstructured":"Ayele B, Nenko G. Treatment outcome of Tuberculosis in selected health facilities of Gedeo zone, Southern Ethiopia: A Retrospective Study. Mycobact Dis. 2015;5:194.","journal-title":"Mycobact Dis"},{"key":"9117_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4172\/2329-891X.1000289","volume":"7","author":"GG Woldeamanuel","year":"2018","unstructured":"Woldeamanuel GG, Mingude AB. Factors associated with mortality in Tuberculosis patients at Debrebirhan referral hospital, Ethiopia: A Retrospective Study. J Trop Dis. 2018;7:289.","journal-title":"J Trop Dis"},{"key":"9117_CR54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12879-018-3167-9","volume":"18","author":"B Demile","year":"2018","unstructured":"Demile B, Zenebu A, Shewaye H. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. BMC Infect Dis. 2018;18:249.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"9117_CR55","first-page":"112","volume":"6","author":"T Zenebe","year":"2016","unstructured":"Zenebe T, Genet C, Tefera E, et al. Effectiveness of observed treatment, short-course (DOTS) on the treatment of tuberculosis patients in the Afar region, Ethiopia. Int J Health Sci Res. 2016;6(8):112\u20138.","journal-title":"Int J Health Sci Res"},{"key":"9117_CR56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12879-016-1917-0","volume":"16","author":"A Asres","year":"2016","unstructured":"Asres A, Jerene D, Deressa W. Tuberculosis treatment outcomes of six and eight-month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study. BMC Infect Dis. 2016;16:653.","journal-title":"BMC Infect Dis"},{"key":"9117_CR57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4236\/jtr.2016.41004","volume":"4","author":"YSA GebreegziabherSB","year":"2016","unstructured":"GebreegziabherSB YSA, Bjune GA. Tuberculosis case notification and treatment outcomes in west Gojjam zone, Northwest Ethiopia: a five-year retrospective study. J Tuberc Res. 2016;4:23\u201333.","journal-title":"J Tuberc Res"},{"issue":"1","key":"9117_CR58","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18034\/mjmbr.v1i1.371","volume":"1","author":"G Asebe","year":"2014","unstructured":"Asebe G, Ameni G, Tafess K. Ten years tuberculosis trend in Gambella regional hospital, South Western Ethiopia. Malays J Med Biol Res. 2014;1(1):156\u20138.","journal-title":"Malays J Med Biol Res"},{"key":"9117_CR59","first-page":"397","volume":"57","author":"T Abebe","year":"2015","unstructured":"Abebe T, Angamo MT. Treatment outcomes and associated factors among tuberculosis patients in Southwest Ethiopia. G\u00fclhane T\u0131p Derg. 2015;57:397\u2013407.","journal-title":"G\u00fclhane T\u0131p Derg"},{"issue":"1","key":"9117_CR60","first-page":"6","volume":"5","author":"J Alemu","year":"2017","unstructured":"Alemu J, Mamo G, Kandi V, et al. Prevalence of Tuberculosis in Gambella regional hospital, Southwest Ethiopia: a retrospective study to assess the Progress towards millennium development goals for Tuberculosis (2006-2015). Am J Public Health Res. 2017;5(1):6\u201311.","journal-title":"Am J Public Health Res"},{"key":"9117_CR61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4172\/2167-1168.1000386","volume":"6","author":"E Tachbele","year":"2017","unstructured":"Tachbele E, Taye B, Tulu B, et al. Treatment outcomes of Tuberculosis patients at bale robe hospital, Oromia regional state, Ethiopia: A Five Year Retrospective Study. J Nurs Care. 2017;6:386.","journal-title":"J Nurs Care"},{"key":"9117_CR62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13104-016-2004-8","volume":"9","author":"D Tarekehne","year":"2016","unstructured":"Tarekehne D, Jema M, Atenaw T. Prevalence of human immunodeficiency virus in the court of tuberculosis at MetemaHospital, northwest Ethiopia: A 3-year retrospective study. BMC Res Note. 2016;9:192.","journal-title":"BMC Res Note"},{"key":"9117_CR63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ijmy.ijmy_48_18","volume":"7","author":"Y Worku","year":"2018","unstructured":"Worku Y, Getinet T, Mohammed S, Yang Z. Drug-resistant Tuberculosis in Ethiopia: characteristics of cases in a referral hospital and the implications. Int J Mycobacterial. 2018;7:167\u201372.","journal-title":"Int J Mycobacterial"},{"key":"9117_CR64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jctube.2018.06.002","volume":"12","author":"E Ejetab","year":"2018","unstructured":"Ejetab E, Beyenea G, Bonsa Z. Xpert MTB\/RIF assay for the diagnosis of mycobacterium tuberculosis and rifampicin resistance in high human immunodeficiency virus setting in Gambella regional state, Southwest Ethiopia. J ClinTuberc Other Mycobact Dis. 2018;12:14\u201320.","journal-title":"J ClinTuberc Other Mycobact Dis"},{"issue":"6","key":"9117_CR65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1371\/journal.pone.0198080","volume":"13","author":"A Shibabaw","year":"2018","unstructured":"Shibabaw A, Gelaw B, Wang S-H, Tessema B. Time to sputum smear and culture conversions in multidrug-resistant tuberculosis at the University of Gondar Hospital Northwest Ethiopia. PLoS One. 2018;13(6):203\u20136.","journal-title":"PLoS One"},{"issue":"10","key":"9117_CR66","doi-asserted-by":"crossref","first-page":"e0206227","DOI":"10.1371\/journal.pone.0206227","volume":"13","author":"AB Muluye","year":"2018","unstructured":"Muluye AB, Kebamo S, Teklie T, et al. Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in east Wollega, Western Ethiopia. PLoS One. 2018;13(10):e0206227.","journal-title":"PLoS One"},{"key":"9117_CR67","first-page":"247","volume":"20","author":"TD Amante","year":"2015","unstructured":"Amante TD, Ahmed TA. Risk factors for unsuccessful tuberculosis treatment outcome (failure, default, and death) in public health institutions, Eastern Ethiopia. Pan Afri Med J. 2015;20:247.","journal-title":"Pan Afri Med J"},{"key":"9117_CR68","volume-title":"Guidelines for surveillance HIV among TB patients","author":"S Tuberculosis","year":"2004","unstructured":"Tuberculosis S. Guidelines for surveillance HIV among TB patients. 2nd ed. Geneva: TB\/HIV working group of the Global Partnership to Stop TB, World Health Organization; 2004.","edition":"2"},{"issue":"2","key":"9117_CR69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5588\/ijtld.18.0363","volume":"23","author":"A Endalamaw","year":"2019","unstructured":"Endalamaw A, Ambachew S, Geremew D. HIV infection and unknown HIV status among tuberculosis patients in Ethiopia: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(2):187\u201394.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"9117_CR70","first-page":"938","volume":"8","author":"R Chimzizi","year":"2004","unstructured":"Chimzizi R, Harries A, Manda E, Khonyongwa A, Salaniponi F. Counseling, HIV testing, and adjunctive cotrimoxazole for TB patients in Malawi: from research to routine implementation. Int J Tuberc Lung Dis. 2004;8(8):938\u201344.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9117_CR71","unstructured":"HIV Prevention in Ethiopia National Road Map 2018\u20132020. Available: https:\/\/ethiopia.unfpa.org\/sites\/default\/files\/pub-pdf: Accessed; Nov 30\/2019."},{"key":"9117_CR72","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40249-019-0594-9","volume":"8","author":"GD Kibret","year":"2019","unstructured":"Kibret GD, Ferede A, Leshargie CT, Wagnew F. Trends, and spatial distributions of HIV prevalence in Ethiopia. Infect Dis Poverty. 2019;8:90.","journal-title":"Infect Dis Poverty"},{"issue":"4","key":"9117_CR73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4236\/jtr.2017.54030","volume":"5","author":"T Volkmann","year":"2017","unstructured":"Volkmann T, Nguyen B, Ebelechukwu G. Comparison of HIV testing among children and adults with Tuberculosis. Vietnam. J Tuberc Res. 2017;5(4):292\u20137.","journal-title":"Vietnam. J Tuberc Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09117-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09117-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09117-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T23:19:22Z","timestamp":1624922362000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09117-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9117"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09117-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study is based on a systematic review of published data and thus does not require ethical clearance","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1021"}}